Walgreen Co Recalls Lantus Insulin Glargine (rDNA origin) Injection

Deerfield, IL  (SafetyAlerts) - The Food and Drug Administration (FDA) said that Walgreen Co. is recalling Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL.

This is the first public notice of this Class llI recall issued by the FDA.

PRODUCT
Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL (U-100)in 10 mL vials, 10 vials per pack; NDC #0088-2220-33,

Recall
# D-029-2.

CODE
All lots of Lantus U-100 Insulin distributed to Walgreens pharmacies between 5/2/01 and 9/7/01.

RECALLING FIRM/MANUFACTURER

Recalling Firm:
Walgreen Co., Deerfield, IL, by e-mail on 9/7/01.

Manufacturer:
Aventis Pharma AG Frankfurt am Main, Germany. Firm initiated recall is complete.

REASON
Temperature Abuse-product shipped unrefrigerated by recalling firm.

VOLUME OF PRODUCT IN COMMERCE
38,000 vials.

DISTRIBUTION
Nationwide.